The Scripps Research Institute
37
6
8
21
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
8.1%
3 terminated/withdrawn out of 37 trials
87.5%
+1.0% vs industry average
11%
4 trials in Phase 3/4
71%
15 of 21 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (37)
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Role: collaborator
Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall Good Health in South Africa.
Role: collaborator
The CDAC Study - Cerebral Dysfunction After Coronary Revascularization
Role: lead
Molecular Studies and Clinical Correlations in Human Prostatic Disease
Role: collaborator
Spironolactone and XPB-1 Integrity in the TFIIH Complex
Role: collaborator
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults
Role: collaborator
Cough Capture as a Portal Into the Lung
Role: collaborator
Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations
Role: collaborator
The MagnaSafe-2 Registry: Assessing the Risks of Magnetic Resonance Imaging in Three Patient Groups
Role: lead
TNBC Gut Microbiota During Neoadjuvant Treatment
Role: collaborator
The iLet Experience Study
Role: collaborator
The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry
Role: collaborator
Medication Development in Alcoholism: Suvorexant Versus Placebo
Role: lead
Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo
Role: lead
Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy
Role: collaborator
Mifepristone Treatment of Alcohol Use Disorder
Role: lead
Medication Development in Alcoholism: Apremilast Versus Placebo
Role: lead
Changes in Cellular Immune Profile During COVID-19 Infection
Role: collaborator
Strategies: Motivational Interviewing/Psychoeducation
Role: collaborator
MAP4343 Treatment for Alcohol Use Disorder
Role: lead